MAPT and Alzheimer disease: In these individuals, elevated tau measured with CSF was associated with several risk factors (older age, male sex, greater WMH burden, and hypertension), as well as a pattern of neurodegeneration that is characteristic of AD (temporoparietal hypometabolism, and hippocampal atrophy).